The price of ERIS Life Sciences as of the end of day 17th April 2023 was INR 612.6 on BSE.
ERIS Life Sciences net profit has increased from Rs. 291.15 crores to Rs. 405.79 crores in the last four years. And the company's sales revenue has grown from Rs.982.6 crores to Rs. 1347 crores in the last four years.
ERIS Life Sciences stock 52 weeks low is Rs.551.3 and high is Rs.749.8.
Equity investment is a risk like any other investment and it is advisable to take professional advice before investing.
The current market value (or market capitalization) of ERIS Life Sciences is approximately Rs. 8.33K crores as on 17th April 2023.
ERIS Life Sciences has a debt-to-equity ratio of 0.13.
Eris Life Sciences is a pharmaceutical company based in India that focuses on developing, manufacturing, and marketing branded pharmaceutical products across various therapeutic areas. The company's products are sold in India and other countries, including Nepal, Sri Lanka, and Mauritius.
However, it is near impossible to predict the future movements of stock prices, as they are linked to a wide range of variables, including market trends, economic conditions, company performance, and global events.
It's imperative to conduct thorough research and due diligence in making any investment decisions. And to consider several relevant factors that could impact the company's future prospects.
ERIS Life Sciences stock has given a positive return of 33.61% over the last 3 years and a negative return of -12.85% over the past 12 months.
Selling or buying of specific stock or stocks depends on your personal financial goals and risk tolerance.